Fundraising Fox

Sinotau

1 known investors

SinoTau is a pharmaceutical company that develops, manufactures, and commercializes radiopharmaceuticals for both diagnostic imaging and therapeutic use. Its pipeline includes radionuclide diagnostic and treatment products, with one product approved by China's NMPA.

BiotechDigital HealthMedical Devices

Investors · 1

Qiming Venture PartnersBeijing · $5M – $134M

In the news

Sinotau aims to become Hong Kong’s ‘first nuclear-medicine stock’ - Bamboo Works - China stock insights for global investorsthebambooworks.com · Jun 2025Sinotau Aims To Be Hong Kong's 'First Nuclear-medicine Stock'sahmcapital.com · Jun 2025China VC Weekly: Flying Cars and More - Pandailypandaily.com · Oct 2021Sinotau Pharmaceutical Group Completes $50 Million D+ Round of Financing with Focus on Radiopharmaceutical R&D - Pandailypandaily.com · Oct 2021Sinotau Pharmaceutical Technology Raises CNY 320 Mn in Series D | EqualOceanequalocean.com · Feb 2021

Frequently asked questions

What does Sinotau do?
SinoTau is a pharmaceutical company that develops, manufactures, and commercializes radiopharmaceuticals for both diagnostic imaging and therapeutic use. Its pipeline includes radionuclide diagnostic and treatment products, with one product approved by China's NMPA.
Who are Sinotau's investors?
Sinotau's investors include Qiming Venture Partners.